Boral Biotech
THE GRUP'S SUBSIDIARY
Our goals
Boral Biotech, the group’s subsidiary whose purpose and main line of activities comprises the creation, participation, management and development of innovative projects with social impact related to the fields of biotechnology, Medtech, digital health, new drugs discoveries and medical devices.
REFERENCE PARTNER
Sabadell Asabys
Asabys is an investment firm based in Barcelona, investing in healthcare and life-sciences innovation. Directly or indirectly, through our reference partner Sabadell Asabys, we actively participate in the following innovative and transformative projects in the world of health.
Health transformative projects invested by Sabadell Asabys
Other projects
ISD
Following a target-based approach and through a solid technological partnership with Nostrum Biodiscovery, they use the most advanced computational techniques to design active molecules for the cosmetic and biotechnological industries.
NBS
Newborn Solutions develops non-invasive technology for detection and monitoring of infections in serous body fluids, with a main focus on infant meningitis, thanks to quick, easy and cost-effective solutions.
Ojer Pharma
Laboratorios Ojer Pharma is a New Technology-Based Company (NEBTs) that focuses all its efforts on the development of innovative pharmaceutical products to provide real solutions in dermatology.
Aortyx
Aortyx is a pioneer company founded by researchers from the IQS School of Engineering and the Hospital Clínic de Barcelona that aims at providing a new generation of endovascular devices to treat vascular diseases.
AEInnova
AEInnova, founded in 2014 by highly qualified researchers and engineers of the Microelectronics Department at the Autonomous University of Barcelona, is one of the TOP30 EU companies (ranked by the European Commission) and the TOP EU innovator in autonomous sensors.
News and Use Cases
Contact us
C/ Nicaragua, 79
08029 Barcelona (Spain)
jpalomo@boralquimica.com
+34 934 303 400
